Evidence map›Paper›PMID 41574687›Full record

ArticleMolecular medicine reports2026

Naringin ameliorates intestinal injury in ulcerative colitis model mice by modulating the JAK2/STAT3 signaling pathway.

Miaomiao Wu, Yating An, Yongmin Li, Wei He, Ying Wang, Yaqi Wang, Caixia Wu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Miaomiao Wu *College of Pharmacy, Hebei North University, Zhangjiakou, Hebei 075000, P.R. China.
Yating An *Pharmaceutical Department, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin 300120, P.R. China.
Yongmin LiCollege of Traditional Chinese Medicine, Hebei University of Chinese Medicine, Shijiazhuang, Hebei 050200, P.R. China.
Wei HeCollege of Traditional Chinese Medicine, Hebei North University, Zhangjiakou, Hebei 075000, P.R. China.
Ying WangCollege of Traditional Chinese Medicine, Hebei North University, Zhangjiakou, Hebei 075000, P.R. China.
Yaqi WangPharmaceutical Department, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin 300120, P.R. China.
Caixia WuCollege of Traditional Chinese Medicine, Hebei North University, Zhangjiakou, Hebei 075000, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ulcerative colitis (UC) is a chronic autoimmune disease characterized by mucosal inflammation and disruption of the intestinal barrier. Current therapies often produce adverse effects, underscoring the need for novel treatment options. Naringin, a flavonoid from

Indexed as

Colitis, UlcerativeFlavanonesJanus Kinase 2Signal TransductionSTAT3 Transcription FactorAnimalsCaco-2 CellsDextran SulfateDisease Models, AnimalHumansIntestinal Barrier FunctionIntestinal MucosaMaleMiceDextran SulfateFlavanonesJak2 protein, mouseJanus Kinase 2naringinStat3 protein, mouseSTAT3 Transcription FactorCitrus aurantium L.intestinal mucosal barrierJAK2/STAT3 signaling pathwaynaringinulcerative colitis

Identifiers

PMID41574687
PMCPMC12865882

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.